• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过超临界抗溶剂法制备用于肺部给药的 5-氟尿嘧啶纳米粒子。

Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery.

机构信息

Aerosol Research Laboratory, Tehran University of Medical Sciences, Iran.

出版信息

Int J Nanomedicine. 2010 Oct 5;5:763-70. doi: 10.2147/IJN.S12415.

DOI:10.2147/IJN.S12415
PMID:21042422
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2962272/
Abstract

This study concerns the supercritical antisolvent process which allows single-step production of 5-fluorouracil (5-FU) nanoparticles. This process enhances the physical characteristics of 5-FU in order to deliver it directly to the respiratory tract. Several mixtures of methanol with dichloromethane, acetone, or ethanol were used for particle preparation, and their effects on the physical characteristics of the final products were studied. The conditions of the experiment included pressures of 100 and 150 bar, temperature of 40°C, and a flow rate of 1 mL/min. The particles were characterized physicochemically before and after the process for their morphology and crystallinity. In spite of differences in size, the particles were not very different regarding their morphology. The resulting particles were of a regular shape, partly spherical, and appeared to have a smooth surface, whereas the mechanically milled particles showed less uniformity, had surface irregularities and a high particle size distribution, and seemed aggregated. Particles of 5-FU precipitated from methanol-dichloromethane 50:50 had a mean particle size of 248 nm. In order to evaluate the aerodynamic behavior of the nanoparticles, six 5-FU dry powder formulations containing mixtures of coarse and fine lactose of different percentages were prepared. Deposition of 5-FU was measured using a twin-stage liquid impinger and analyzed using a validated high pressure liquid chromatography method. Addition of fine lactose improved the aerodynamic performance of the drug, as determined by the fine particle fraction.

摘要

本研究涉及超临界抗溶剂过程,该过程可一步生产 5-氟尿嘧啶(5-FU)纳米颗粒。该过程增强了 5-FU 的物理特性,以便将其直接递送至呼吸道。使用甲醇与二氯甲烷、丙酮或乙醇的几种混合物来制备颗粒,并研究了它们对最终产物物理特性的影响。实验条件包括 100 和 150 巴的压力、40°C 的温度和 1 毫升/分钟的流速。在该过程前后,对颗粒的形态和结晶度进行了物理化学性质的表征。尽管粒径存在差异,但颗粒的形态差异不大。所得颗粒形状规则,部分呈球形,表面似乎光滑,而机械研磨的颗粒则不太均匀,表面不规则,粒径分布较宽,似乎团聚。从甲醇-二氯甲烷 50:50 中沉淀的 5-FU 颗粒的平均粒径为 248nm。为了评估纳米颗粒的空气动力学行为,制备了六种包含不同比例粗乳糖和细乳糖混合物的 5-FU 干粉制剂。使用双级液体冲击器测量 5-FU 的沉积,并使用经过验证的高压液相色谱法进行分析。细乳糖的添加改善了药物的空气动力学性能,这是由细颗粒分数决定的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a3/2962272/d2cd6d4c21e1/ijn-5-763f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a3/2962272/eff20ffbe37b/ijn-5-763f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a3/2962272/9986d8eb74b7/ijn-5-763f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a3/2962272/781b359c2735/ijn-5-763f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a3/2962272/2b532399dea5/ijn-5-763f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a3/2962272/3dac00a3e6fd/ijn-5-763f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a3/2962272/d2cd6d4c21e1/ijn-5-763f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a3/2962272/eff20ffbe37b/ijn-5-763f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a3/2962272/9986d8eb74b7/ijn-5-763f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a3/2962272/781b359c2735/ijn-5-763f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a3/2962272/2b532399dea5/ijn-5-763f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a3/2962272/3dac00a3e6fd/ijn-5-763f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a3/2962272/d2cd6d4c21e1/ijn-5-763f6.jpg

相似文献

1
Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery.通过超临界抗溶剂法制备用于肺部给药的 5-氟尿嘧啶纳米粒子。
Int J Nanomedicine. 2010 Oct 5;5:763-70. doi: 10.2147/IJN.S12415.
2
Stability and aerodynamic behaviour of glucocorticoid particles prepared by a supercritical fluids process.超临界流体法制备的糖皮质激素颗粒的稳定性及空气动力学行为
Eur J Pharm Sci. 2004 Mar;21(4):501-9. doi: 10.1016/j.ejps.2003.11.006.
3
Effect of supercritical fluid density on nanoencapsulated drug particle size using the supercritical antisolvent method.利用超临界抗溶剂法研究超临界流体密度对纳米包埋药物颗粒大小的影响。
Int J Nanomedicine. 2012;7:2165-72. doi: 10.2147/IJN.S29805. Epub 2012 Apr 27.
4
Supercritical antisolvent-fluidized bed for the preparation of dry powder inhaler for pulmonary delivery of nanomedicine.超临/界反溶剂流化床技术在制备肺部给药纳米药物干粉吸入剂中的应用。
Int J Pharm. 2023 Dec 15;648:123580. doi: 10.1016/j.ijpharm.2023.123580. Epub 2023 Nov 7.
5
Chitosan nanoparticles of 5-fluorouracil for ophthalmic delivery: characterization, in-vitro and in-vivo study.用于眼部给药的5-氟尿嘧啶壳聚糖纳米粒:表征、体外和体内研究
Chem Pharm Bull (Tokyo). 2011;59(2):272-8. doi: 10.1248/cpb.59.272.
6
Optimizing supercritical antisolvent process parameters to minimize the particle size of paracetamol nanoencapsulated in L-polylactide.优化超临界抗溶剂工艺参数,以最小化 L-聚乳酸包埋对乙酰氨基酚纳米颗粒的粒径。
Int J Nanomedicine. 2011;6:1101-5. doi: 10.2147/IJN.S18979. Epub 2011 May 30.
7
Preparation and physicochemical properties of 10-hydroxycamptothecin (HCPT) nanoparticles by supercritical antisolvent (SAS) process.超临界抗溶剂(SAS)法制备10-羟基喜树碱(HCPT)纳米颗粒及其理化性质
Int J Mol Sci. 2011;12(4):2678-91. doi: 10.3390/ijms12042678. Epub 2011 Apr 20.
8
Preparation and physicochemical properties of vinblastine microparticles by supercritical antisolvent process.超临界抗溶剂法制备长春碱微粒及其理化性质
Int J Mol Sci. 2012 Oct 3;13(10):12598-607. doi: 10.3390/ijms131012598.
9
The effect of water to ethanol feed ratio on physical properties and aerosolization behavior of spray dried cromolyn sodium particles.水与乙醇进料比对喷雾干燥色甘酸钠颗粒物理性质及雾化行为的影响。
J Pharm Sci. 2005 May;94(5):1048-59. doi: 10.1002/jps.20315.
10
Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.采用新型超临界 CO2 技术制备并表征载 5-氟尿嘧啶的 PLLA-PEG/PEG 纳米粒。
Int J Pharm. 2012 Oct 15;436(1-2):272-81. doi: 10.1016/j.ijpharm.2012.06.022. Epub 2012 Jun 18.

引用本文的文献

1
Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery.吸入式纳米颗粒系统:组成、制造和气溶胶传递。
J Aerosol Med Pulm Drug Deliv. 2024 Aug;37(4):202-218. doi: 10.1089/jamp.2024.29117.mk.
2
Co-delivery of paclitaxel and curcumin loaded solid lipid nanoparticles for improved targeting of lung cancer: and investigation.载有紫杉醇和姜黄素的固体脂质纳米粒共递送用于改善肺癌靶向性:一项研究
Heliyon. 2024 Apr 26;10(9):e30290. doi: 10.1016/j.heliyon.2024.e30290. eCollection 2024 May 15.
3
Engineering Inhalable Therapeutic Particles: Conventional and Emerging Approaches.

本文引用的文献

1
Feasibility study of postoperative adjuvant chemotherapy with S-1 (tegaful, gimeracil, oteracil potassium) for non-small cell lung cancer-LOGIK 0601 study.替吉奥(替加氟、吉美嘧啶、奥替拉西钾)术后辅助化疗治疗非小细胞肺癌的可行性研究-LOGIK0601 研究。
Lung Cancer. 2010 Feb;67(2):184-7. doi: 10.1016/j.lungcan.2009.03.028. Epub 2009 May 5.
2
Lung cancer and treatment in elderly patients: the Achilles Study.老年患者的肺癌与治疗:阿喀琉斯研究
Lung Cancer. 2009 Oct;66(1):103-6. doi: 10.1016/j.lungcan.2008.12.021. Epub 2009 Feb 4.
3
Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery.
工程化可吸入治疗颗粒:传统方法与新兴方法
Pharmaceutics. 2023 Nov 30;15(12):2706. doi: 10.3390/pharmaceutics15122706.
4
Measurement and Correlation of the Solubility of 5-Fluorouracil in Pure and Binary Solvents.5-氟尿嘧啶在纯溶剂和二元溶剂中的溶解度测定及关联
J Chem Eng Data. 2018 Oct 11;63(10):3809-3817. doi: 10.1021/acs.jced.8b00425. Epub 2018 Oct 2.
5
Emerging delivery approaches for targeted pulmonary fibrosis treatment.靶向肺纤维化治疗的新兴给药途径。
Adv Drug Deliv Rev. 2024 Jan;204:115147. doi: 10.1016/j.addr.2023.115147. Epub 2023 Dec 6.
6
Antitumor Effect of Bleomycin Nanoaerosol in Murine Carcinoma Model.博来霉素纳米气雾剂对小鼠癌模型的抗肿瘤作用。
Molecules. 2023 May 18;28(10):4157. doi: 10.3390/molecules28104157.
7
Preparation and in vitro evaluation of hesperidin nanoparticles by antisolvent recrystallization in a double homogenate system.在双均质体系中通过反溶剂重结晶法制备橙皮苷纳米颗粒及其体外评价
Food Chem X. 2023 Mar 13;18:100639. doi: 10.1016/j.fochx.2023.100639. eCollection 2023 Jun 30.
8
Drug Release from Nanoparticles (Polymeric Nanocapsules and Liposomes) Mimed through a Multifractal Tunnelling-Type Effect.通过多重分形隧穿型效应模拟的纳米颗粒(聚合物纳米囊和脂质体)药物释放
Polymers (Basel). 2023 Feb 17;15(4):1018. doi: 10.3390/polym15041018.
9
Supercritical Fluids and Nanoparticles in Cancer Therapy.癌症治疗中的超临界流体与纳米颗粒
Micromachines (Basel). 2022 Sep 1;13(9):1449. doi: 10.3390/mi13091449.
10
Dry Powder for Pulmonary Delivery: A Comprehensive Review.肺部给药干粉剂:全面综述
Pharmaceutics. 2020 Dec 28;13(1):31. doi: 10.3390/pharmaceutics13010031.
利用声致结晶法进行颗粒工程:用于肺部给药的硫酸沙丁胺醇
Int J Pharm. 2009 Feb 23;368(1-2):129-37. doi: 10.1016/j.ijpharm.2008.10.006. Epub 2008 Oct 18.
4
Nanoparticle formulations in pulmonary drug delivery.肺部药物递送中的纳米颗粒制剂
Med Res Rev. 2009 Jan;29(1):196-212. doi: 10.1002/med.20140.
5
Regional differences in treatment and outcome in non-small cell lung cancer: a population-based study (Sweden).非小细胞肺癌治疗与结局的地区差异:一项基于人群的研究(瑞典)
Lung Cancer. 2009 Jan;63(1):16-22. doi: 10.1016/j.lungcan.2008.05.011. Epub 2008 Jun 20.
6
Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosis.通过透明质酸微球将氧氟沙星递送至肺部和肺泡巨噬细胞用于治疗结核病。
J Control Release. 2008 Jul 14;129(2):100-6. doi: 10.1016/j.jconrel.2008.04.009. Epub 2008 Apr 22.
7
Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.采用超临界抗溶剂(SAS)法制备、表征及体内评价无定形阿托伐他汀钙纳米粒
Eur J Pharm Biopharm. 2008 Jun;69(2):454-65. doi: 10.1016/j.ejpb.2008.01.007. Epub 2008 Jan 18.
8
Inhaled nanoparticles--a current review.吸入性纳米颗粒——当前综述
Int J Pharm. 2008 May 22;356(1-2):239-47. doi: 10.1016/j.ijpharm.2008.02.011. Epub 2008 Feb 16.
9
Aerodynamical, immunological and pharmacological properties of the anticancer antibody cetuximab following nebulization.雾化后抗癌抗体西妥昔单抗的空气动力学、免疫学和药理学特性
Pharm Res. 2008 Jun;25(6):1318-26. doi: 10.1007/s11095-007-9481-3.
10
Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.用于干粉吸入器的硫酸沙丁胺醇/异丙托溴铵及硫酸沙丁胺醇/辅料喷雾干燥混合物的物理化学性质和体外沉积特性
Int J Pharm. 2006 Sep 28;322(1-2):22-30. doi: 10.1016/j.ijpharm.2006.05.022. Epub 2006 May 16.